eonatal Colonisation and Infection with Ureaplasma in very immature preterm infants born < 29 weeks of gestatio

• Conditions: P27.1; P52; P36.9; P39.9; P77; P91.1; H35.1; P23.9; P28.5; G80

• Registration Number: DRKS00033001
• Lead Sponsor: niversitätsklinikum Würzburg, Kinderklinik und Poliklinik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-05-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Inborn patient
Written parental consent

Exclusion Criteria

Severe or letal malformations

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Risk of development of bronchopulmonary dysplasie at 36 weeks or combined outcome BPD / death before 36 weeks of gestation

Secondary Outcome Measures

Name	Time	Method
(a) Risk of perinatal inflammation with elevated cord blood cytokines / chemokines and persistance for 4 weeks postnatally <br>(b) Risk of complications (infection, sepsis, intraventricular hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, retinopathia praematurorum) <br>(c) Risk of developmental retardation at the corrected age of 24 months